11 Mar 24

EINDHOVEN, the Netherlands — March 11, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that it has been accepted into the US FDA’s newTotal Product Lifecycle Advisory Program (TAP)for its brain-computer interface (BCI) technology.

29 Feb 24
EINDHOVEN, the Netherlands — February 29, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces it has been awarded Breakthrough Device Designation (BDD) by the US Food and Drug Administration (FDA) for the ARC-BCI System, which uses brain-computer interface (BCI) technology in conjunction with its ARC-IM®Therapy to restore thought-driven lower limb mobility after spinal cord injury (SCI).
09 Feb 24
EINDHOVEN, the Netherlands — February 9, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announced that KBC Securities, part of the KBC Group -- a leading Belgian integrated bank-insurance group -- has initiated research coverage of ONWARD Medical with a Buy rating and Target Price of EUR 10.00 per share.
07 Feb 24
EINDHOVEN, the Netherlands — February 7, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces its participation in BioCapital Europe in Amsterdam on February 8, 2024.

Upcoming Events

More events are coming soon.